Aspen Pharmacare is set to receive a long-term funding package of nearly $713m (€600m) to boost the production of Coivd-19 vaccines for countries in the African continent.
Earlier, the same firms were accused and booked for selling Coldbest cough syrup which contained DEG and caused the death of nine children in Jammu and Kashmir.